Scientists at the UNC Eshelman School of Pharmacy are creating white blood cells that teach brain cells to heal the damage caused by degenerative neurological disorders like Parkinson’s disease
As a potential treatment for Parkinson’s disease, scientists at the University of North Carolina at Chapel Hill have created smarter immune cells that produce and deliver a healing protein to the brain while also teaching neurons to begin making the protein for themselves.
The researchers, led by Elena Batrakova, an associate professor at the UNC Eshelman School of Pharmacy’s Center for Nanotechnology in Drug Delivery, genetically modified white blood cells called macrophages to produce glial cell–derived neurotrophic factor, or GDNF, and deliver it to the brain. Glial cells provide support and protection for nerve cells throughout the brain and body, and GDNF can heal and stimulate the growth of damaged neurons.
“Currently, there are no treatments that can halt or reverse the course of Parkinson’s disease. There are only therapies to address quality of life, such as dopamine replacement,” Batrakova said. “However, studies have shown that delivering neurotrophic factor to the brain not only promotes the survival of neurons but also reverses the progression of Parkinson’s disease.”
In addition to delivering GDNF, the engineered macrophages can “teach” neurons to make the protein for themselves by delivering both the tools and the instructions needed: DNA, messenger RNA and transcription factor.
Successfully delivering the treatment to the brain is the key to the success of GDNF therapy, said Batrakova. Using immune cells avoids the body’s natural defenses. The repurposed macrophages are also able to penetrate the blood-brain barrier, something most medicines cannot do. The reprogrammed cells travel to the brain and produce tiny bubbles called exosomes that contain GDNF. The cells release the exosomes, which then are able to deliver the proteins to neurons in the brain. The work is described in an article published online by PLOS One.
“By teaching immune system cells to make this protective protein, we harness the natural systems of the body to combat degenerative conditions like Parkinson’s disease,” Batrakova said.
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Parkinson's Foundation hosts professional education training in Bostonon November 14, 2019 at 9:22 am
NEW YORK & MIAMI--November 14, 2019--The Parkinson's Foundation announced the spring location of its biannual signature professional education course, Allied Team Training for Parkinson's, ATTP® in ...
- Inflammatory bowel disease appears to impact risk of Parkinson's diseaseon November 14, 2019 at 9:09 am
Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal ...
- Parkinson’s Disease: Complications You Should Be aware ofon November 13, 2019 at 10:15 pm
Characterized by tremor, slowed movement, impaired posture, rigid muscles, etc, Parkinson’s is a progressive neurological disorder. In the early stages, it doesn’t show any signs. They appear in the ...
- Why do many people with Parkinson’s disease develop an addiction? We built a virtual casino to find outon November 13, 2019 at 11:06 am
He also received an unrestricted educational grant from Medtronic. Parkinson’s disease is a progressive neurodegenerative disorder affecting one in 350 Australians. It’s caused by the loss of cells ...
- Targeting alpha-synuclein in the gut may slow down Parkinson's diseaseon November 13, 2019 at 9:42 am
Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of Parkinson's disease (PD). Investigators are testing the hypothesis that by targeting the enteric ...
- Parkinson’s Disease Drugs Market 2019: Comprehensive Analysis on Business Summary, Product Opportunity and Current Industry Development 2024on November 12, 2019 at 9:41 pm
Nov 13, 2019 (The Expresswire) -- Parkinson's Disease Drugs Market analysis report contains all study material about Market Overview, Growth, Demand and Forecast Research in all over the world.
- 'Moving Day Jacksonville' gives voice to families living with Parkinson's diseaseon November 12, 2019 at 9:23 am
“Something was not quite right.” After doctor visits and testing, the reason became apparent in February 2018. The Jacksonville woman had Parkinson’s disease, a progressive neurodegenerative disorder ...
- Scientists propose new theory of Parkinson's diseaseon November 12, 2019 at 9:05 am
As scientists delve deeper into the nature of Parkinson's, the more it appears that it is highly varied, suggesting numerous subtypes. A new review proposes that Parkinson's falls into one of two main ...
- Yorktown star Bruce Parkinson to join Purdue Athletics Hall of Fameon November 12, 2019 at 8:31 am
WEST LAFAYETTE - One of the greatest basketball players in Yorktown High School history will be joining the Purdue Athletics Hall of Fame this winter. Bruce Parkinson, a 1972 Yorktown grad who led the ...
- Parkinson's Foundation and Parkinson's UK form new partnershipon November 12, 2019 at 4:11 am
Each year, Parkinson's UK, their supporters and partners invest more than £4 million into the Parkinson's Virtual Biotech to rapidly develop and test the most promising research findings with the aim ...
via Bing News